Feasibility of genetic and immunological prediction of Type I diabetes in a population-based birth cohort

Diabetologia

Volumn 44, Issue 3, 2001, Pages 290-297

  Kupila, A ^a   Muona, P ^a   Simell, T ^a   Arvilommi, P ^a   Savolainen, H ^a   Hamalainen A M ^a   Korhonen, S ^a   Kimpimaki T ^a   Sjoroos M ^a   Ilonen, J ^a   Knip, M ^a   Simell, O ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

Autoantibodies; Finland; Follow up studies; HLA DQ antigens; Infant; Mass screening; Population surveillance; Risk assessment

Indexed keywords

AUTOANTIBODY; HLA DQ ANTIGEN;

ARTICLE; AUTOIMMUNITY; COHORT ANALYSIS; FEMALE; FINLAND; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SCREENING; GENOTYPE; HUMAN; IMMUNOSURVEILLANCE; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN SCREENING; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL;

ALLELES; AUTOANTIBODIES; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; FEASIBILITY STUDIES; FEMALE; FINLAND; FOLLOW-UP STUDIES; GENETIC SCREENING; GENOTYPE; HLA-DQ ANTIGENS; HUMANS; INCIDENCE; INFANT, NEWBORN; ISLETS OF LANGERHANS; LONGITUDINAL STUDIES; MALE; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 0035079772     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051616     Document Type: Article

References (28)

1. Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals
2. Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy
3. Insulin-dependent diabetes mellitus as an autoimmune disease
4. Insulin prophylaxis in individuals at high risk of type I diabetes
5. Delay of Type I diabetes in high risk, first degree relatives by parenteral antigen administration: The Schwabing Insulin Prophylaxis Pilot Trial
6. Preventing insulin dependent diabetes mellitus
7. The Diabetes Prevention Trial-Type 1 diabetes (DPT-1): Implementation of screening and staging of relatives
8. Population based genetic screening for Type 1 diabetes mellitus risk in Finland: Selective genotyping of the markers in the HLA-DQB1, HLA-DQA1 and HLA-DRB1 loci
9. Record-high incidence of Type I (insulin-dependent) diabetes mellitus in Finnish children
10. Interactions of age, islet cell antibodies, insulin autoantibodies, and first-phase insulin response in predicting risk of progression to IDDM in ICA + relatives: The ICARUS data set
11. Immunogenetic determinants and prediction of IDDM in French schoolchildren
12. Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type 1 (insulin-dependent) diabetes mellitus
13. Islet cell antibodies as predictive markers for IDDM in children with high background incidence of disease
14. A novel micro-assay for insulin autoantibodies
15. Autoantibodies associated with Type I diabetes mellitus persist after diagnosis in children
16. IA-2 antibodies - A sensitive marker of IDDM with clinical onset in childhood and adolescence
17. Triple-label hybridization assay for type-1 diabetes-related HLA alleles
18. Standardization of IVGTT to predict IDDM
19. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies
20. Staging of preclinical type 1 diabetes in siblings of affected children
21. Prediction of IDDM in the general population: Strategies based on combinations of autoantibody markers
22. Islet cell antibodies are less predictive of IDDM among unaffected children in the general population than in sibs of children with diabetes
23. Islet cell antibodies predict insulin-dependent diabetes in United States school age children as powerfully as in unaffected relatives
24. Costs of predicting IDDM
25. Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study
26. Oral tolerance: Immune mechanisms and treatment of autoimmune diseases
27. Perinatal autoimmunity in offspring of diabetic parents. The German Multicenter BABY-DIAB study: Detection of humoral immune responses to islet antigens in early childhood
28. Newborn screening for HLA markers associated with IDDM: Diabetes autoimmunity study in the young (DAISY)